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Résumé en
anglais
Cystic fibrosis (CF) is the major genetic inherited disease in Caucasian populations.
The respiratory tract of CF patients displays a sticky viscous mucus, which allows for
the entrapment of airborne bacteria and fungal spores and provides a suitable
environment for growth of microorganisms, including numerous yeast and filamentous
fungal species. As a consequence, respiratory infections are the major cause of
morbidity and mortality in this clinical context. Although bacteria remain the most
common agents of these infections, fungal respiratory infections have emerged as an
important cause of disease. Therefore, the International Society for Human and
Animal Mycology (ISHAM) has launched a working group on Fungal respiratory
infections in Cystic Fibrosis (Fri-CF) in October 2006, which was subsequently
approved by the European Confederation of Medical Mycology (ECMM). Meetings of
this working group, comprising both clinicians and mycologists involved in the follow-
up of CF patients, as well as basic scientists interested in the fungal species involved,
provided the opportunity to initiate collaborative works aimed to improve our
knowledge on these infections to assist clinicians in patient management. The current
review highlights the outcomes of some of these collaborative works in clinical
surveillance, pathogenesis and treatment, giving special emphasis to standardization
of culture procedures, improvement of species identification methods including the
development of nonculture-based diagnostic methods, microbiome studies and
identification of new biological markers, and the description of genotyping studies
aiming to differentiate transient carriage and chronic colonization of the airways. The
review also reports on the breakthrough in sequencing the genomes of the main
Scedosporium species as basis for a better understanding of the pathogenic
mechanisms of these fungi, and discusses treatment options of infections caused by
multidrug resistant microorganisms, such as Scedosporium and Lomentospora species
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